CD8A and cancer: Extracellular ATP, released in TME by cancer cells and infiltrating inflammatory cells, interacts with P2X7R expressed by DCs to stimulate IL-1β release, which in turn increase CD4+ and CD8+ T cells, mediating antitumor responses [125].